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T cell activationTo investigate the events leading to the depletion of CD4+ T lymphocytes during long-term infection of human
immunodeﬁciency virus type 1 (HIV-1), we infected human CD34+ cells-transplanted NOD/SCID/IL-2Rγnull
mice with CXCR4-tropic and CCR5-tropic HIV-1. CXCR4-tropic HIV-1-infected mice were quickly depleted of
CD4+ thymocytes and both CD45RA+ naïve and CD45RA− memory CD4+ T lymphocytes, while CCR5-tropic
HIV-1-infectedmice were preferentially depleted of CD45RA−memory CD4+ T lymphocytes. Staining of HIV-1
p24 antigen revealed that CCR5-tropic HIV-1 preferentially infected effector memory T lymphocytes (TEM)
rather than centralmemory T lymphocytes. In addition, themajority of p24+ cells in CCR5-tropicHIV-1-infected
micewere activated and in cycling phase. Taken together, ourﬁndings indicate that productive infectionmainly
takes place in the activated TEM in cycling phase and further suggest that the predominant infection in TEM
would lead to the depletion of memory CD4+ T lymphocytes in CCR5-tropic HIV-1-infected mice.
© 2009 Elsevier Inc. All rights reserved.Introduction
While it is evident that human immunodeﬁciency virus type 1
(HIV-1) causes acquired immunodeﬁciency syndrome (AIDS) in
humans, the mechanism by which HIV-1 accomplishes this remains
unclear. The gradual loss of peripheral blood (PB) CD4+ T lymphocytes
during the asymptomatic phase of HIV-1 infection is one of the best
prognostic predictors for the onset of AIDS (O'Brien et al., 1996), and
CD4+ T lymphocyte depletion is thought to be a serious pathological
change in AIDS (McCune, 2001).
To deﬁne the mechanisms behind CD4+ T lymphocyte depletion, a
large number of studies have been conducted in humans, primates,
and humanized mice by using HIV-1, simian immunodeﬁciency virus
(SIV), and SIV/HIV-1 chimeric virus (SHIV) (Centlivre et al., 2007;
Koyanagi et al., 2008; McCune, 2001). One of the important ﬁndings
from previous studies was the dependence of pathogenesis on the co-
receptor preference, CXCR4, and/or CCR5 (Berkowitz et al., 1998;
Moore et al., 2004). CXCR4-tropic (X4) SHIV caused rapid and
complete depletion of all subsets of CD4+ T lymphocytes in rhesus
macaques, which led to death from immunodeﬁciency (Nishimura etyanagi).
ll rights reserved.al., 2004). On the other hand, CCR5-tropic (R5) HIV-1 is the dominant
type of HIV-1 found in patients, and clinical manifestation of HIV-1
infection resembles CCR5-tropic SIV infection (Berger, Murphy, and
Farber, 1999). In both HIV-1-infected patients and SIV-infected rhesus
macaques, the drastic onset of immunodeﬁciency is rare (Ambrose et
al., 2007; McCune, 2001), and CD4+ T lymphocytes in PB slowly
decrease in number, eventually leading to immunodeﬁciency.
X4 virus uses CXCR4 as the co-receptor and R5 virus uses CCR5 as
the co-receptor for viral infection into target cells (Berger, Murphy,
and Farber, 1999; Lusso, 2006). CXCR4 is expressed on naïve T
lymphocytes and thymocytes, thus X4 HIV-1 can infect naïve T
lymphocytes and thymocytes (Pedroza-Martins et al., 1998). It is well
known that faster depletion of immature thymocytes and T
lymphocytes is observed after the appearance of X4 HIV-1 (Berkowitz
et al., 1998; Pedroza-Martins et al., 1998; Schnittman et al., 1990). On
the contrary, CCR5 is primarily expressed on CD4+ effector memory T
lymphocytes (TEM) and macrophages but not on naïve and central
memory CD4+ T lymphocytes (TCM) (Sallusto, Geginat, and Lanza-
vecchia, 2004). Therefore, the selective infection of TEM is thought to
leave naïve T lymphocytes and TCM intact. Depletion of TEM by R5 virus
has been studied in SIV-infected rhesus macaques (Brenchley et al.,
2004; Li et al., 2005). In 14–28 days following infection, the
population of extra-lymphoid CCR5+ TEM was depleted up to 90%
(Centlivre et al., 2007; Mattapallil et al., 2005; Okoye et al., 2007). At
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found in the PB. In an attempt to compensate for the loss of CCR5+
TEM, CCR5− TCM was persistently activated and divided in order to
prevent the collapse of the TEM compartment (Brenchley, Price, and
Douek, 2006). However, CCR5− TCM lose their regenerative capability
after prolonged period of proliferation, leading to decrease in both TCM
and TEM compartments (Brenchley, Price, and Douek, 2006). This
continuous shortage in CCR5+ TEM and accompanying CCR5− TCM
exhaustion are thought to play an important role in the progression to
AIDS (Centlivre et al., 2007). Although the overloading of CD4+
memory T lymphocyte homeostasis serves a compelling model of
immunodeﬁciency in SIV infection, its relevance in HIV-1 infection is
still poorly deﬁned. Therefore, it is necessary that memory T lym-
phocyte infection is studied in an experimental animal model recons-
tituted with competent human immune cells.
To investigate the dynamics of CD4+ T lymphocyte depletion
following HIV-1 infection and the status of HIV-1-producing cells in
vivo, we infected human CD34+ cells-transplanted newborn NOG
mice (NOG-hCD34 mice) with HIV-1JR-CSF (R5 HIV-1) or HIV-1NL4-3Fig. 1. Longitudinal analysis on plasma viral load and CD4+ T lymphocytes in the PB of R5 and
TCID50 of HIV-1JR-CSF (n=7) or HIV-1NL4-3 (n=8) between 12 and 13 weeks olds. (A) The lon
infected (right) mice. (B–D) PB was routinely sampled and analyzed for CD45RA expression
HIV-1NL4-3-infected (n=8) mice. We assigned data into 7 periodic groups (data taken at 0, b
standard deviation were calculated using data obtained from each mouse during each tim
lymphocytes in the peripheral CD45+ cells are shown. Error bars show standard deviations.
and asterisks represent statistical difference when compared to the value obtained from th(X4 HIV-1). Our ﬁndings indicate that X4 HIV-1 infection can cause
the depletion of CD4+ thymocytes which results in the reduction in
both naïve and memory T lymphocytes, while R5 HIV-1 infection can
selectively deplete memory CD4+ T lymphocytes. Further analyses
indicate that R5 HIV-1 preferentially infects CCR7− TEM and that the
infected cells are predominantly activated and in an actively proli-
ferating state. These results suggest that preferential infection in the
activated TEM leads to selective depletion of memory CD4+ T lympho-
cytes in R5 HIV-1-infected patients.
Results
Kinetics of PB CD4+ T lymphocyte depletion in R5 and X4 HIV-1-infected
mice
NOG-hCD34 mice were generated by human CD34+ hematopoi-
etic stem cell transplantation into neonatal NOG mice as described
previously (Baenziger et al., 2006; Traggiai et al., 2004). A signiﬁcant
level of human leukocytes was maintained in the whole PB of 13–44X4 HIV-1-infected mice. NOG-hCD34 mice were intraperitoneally injected with 1×105
gitudinal analysis on the plasma viral load of HIV-1JR-CSF-infected (left) and HIV-1NL4-3-
in CD4+ T lymphocytes from mock-infected (n=8), HIV-1JR-CSF-infected (n=7), and
etween 1–3, 4–6, 7–9, 10–12, 13–15, and 16–18 wpi), and the average percentage and
e period. The percentages of CD4+ (B), CD45RA+CD4+ (C), and CD45RA−CD4+ (D) T
Daggers represent statistical difference (Pb0.05) when compared to the value at 0 wpi,
e mock-infected mice.
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organs such as thymus, bone marrow, spleen and lymph nodes were
highly repopulated with human mononuclear cells (Supplemental
Figs. 1B–E). The expression of CCR5 was mainly restricted within
the CD45RA− memory subset in CD4+ T lymphocytes, and CXCR4
was broadly expressed on both naïve and memory T lymphocytes
(Fig. 4C and data not shown) as observed in humans (Ebert and
McColl, 2001).
NOG-hCD34 mice were inoculated with either an R5 HIV-1 (HIV-
1JR-CSF) or an X4 HIV-1 (HIV-1NL4-3) between 12 and 13 weeks old.
HIV-1 RNA was detected in the plasma of these mice as early as
3 weeks post-infection (wpi) and was maintained at high levels
(1×104 to 106 copies per milliliter) until 28 wpi or until sacriﬁced
(Fig. 1A). PB of these mice was then analyzed for longitudinal
changes in CD4+ T lymphocytes by ﬂow cytometry. In the PB of both
HIV-1JR-CSF-infected andHIV-1NL4-3-infectedmice, depletion of human
CD4+ T lymphocytes was consistently found (Fig. 1B). In HIV-1NL4-3-
infectedmice, both CD4+CD45RA+naïve and CD4+CD45RA−memory
T lymphocytes were depleted, whereas in HIV-1JR-CSF-infected mice,
CD4+CD45RA− memory T lymphocytes were speciﬁcally depleted
(Figs. 1C and D). These data indicate that the infectionwith HIV-1NL4-3
caused faster and more severe depletion of both naïve and memory
subsets of CD4+ T lymphocytes and the infection with HIV-1JR-CSF
preferentially depleted memory CD4+ T lymphocytes.
Thymopathy in X4 HIV-1-infected mice
To investigate the effect of HIV-1 infection on the thymopoiesis in
NOG-hCD34 mice, the thymocytes from HIV-1-infected and mock-
infected mice were isolated and were analyzed with ﬂow cytometry.
In mock-infected and HIV-1JR-CSF-infected mice, CD4 and CD8 double
positive (DP) thymocytes were predominant (Fig. 2A). CD4 single
positive (SP) and CD8 SP thymocytes together made up a major
fraction of the thymocyte population, and double negative (DN)
thymocytes were only a minor fraction. In contrast, thymi from
HIV-1NL4-3-infected mice were severely depleted of both CD4 SP
thymocytes and DP thymocytes (Figs. 2A–C). Furthermore, thymi
from HIV-1NL4-3-infected mice had greatly reduced number of all
subsets of thymocytes (Fig. 2D). CD4 SP and DP thymocytes showed
the greatest (approximately 100-fold) reduction, while CD8 SP
thymocytes showed relatively milder (approximately 10-fold) reduc-
tion (Fig. 2D). These data indicate that infection with HIV-1NL4-3 led toFig. 2. Thymopathy in X4 HIV-1-infected mice. (A) Representative proﬁle of ﬂow cytometric
dot plots indicate the percentage of cells in CD45+ thymocytes. (B and C) CD4/CD8 ratio (B)
1JR-CSF-infected (n=5), and HIV-1NL4-3-infected (n=6)mice. (D) Number of CD45+, CD4 SP,
HIV-1NL4-3-infected (n=8) mice. The horizontal bars in D show the average values, and the
(Pb0.05) when compared to mock-infected mice, and daggers indicate statistical signiﬁcandisturbed thymopoiesis and that HIV-1JR-CSF infection did not affect
thymopoiesis.
Histological detection of p24-positive cells
HIV-1 p24-positive cells productively produce HIV-1 virions. Since
human CD45+ mononuclear cells were very few or absent in HIV-
1NL4-3-infected mice when sacriﬁced, they were not further analyzed
(data not shown). As presented in Fig. 3, the immunohistological
staining showed the presence of HIV-1 p24-positive cells in all of the
bone marrow, spleen, and lymph nodes. HIV-1 p24 staining co-
localized with CD4 staining. Also, a larger percentage of cells seemed
to be productively infected with HIV-1 in the spleen and lymph nodes.
Depletion of splenic memory CD4+ T lymphocytes
We isolated mononuclear cells from the spleen of HIV-1JR-CSF-
infected and mock-infected mice and then analyzed them by ﬂow
cytometry. As shown in Fig. 4A, the percentage of CD4+ T lymphocytes
in the spleen of HIV-1JR-CSF mice was smaller than that of mock-
infected mice by 2.7-fold (P=0.003), showing that HIV-1JR-CSF-
infected mice had signiﬁcantly fewer splenic CD4+ T lymphocytes.
Moreover, the percentage of splenic CD4+CD45RA− memory T
lymphocytes in HIV-1JR-CSF-infected mice was smaller than that in
the mock-infected mice (P=0.007), whereas the percentages of
splenic CD4+CD45RA+ naive T lymphocytes were indifferent
(P=0.17) (Fig. 4B). In mock-infected mice, a signiﬁcant fraction of
CD4+CD45RA− T lymphocytes were CCR5+ memory T lymphocytes
(Fig. 4C). In contrast, in HIV-1JR-CSF-infected mice, we found approx-
imately 20-fold reduction in the percentage (Fig. 4C) and 100-fold
reduction in the number of CD4+CD45RA−CCR5+memory T lympho-
cytes (data not shown). These results suggest that the CCR5-
expressing memory CD4+ T lymphocytes are depleted by direct R5
HIV-1 infection and that such reduction of CCR5-expressing CD4+ T
lymphocytes would lead to the decrease in whole memory CD4+ T
lymphocytes.
Preferential HIV-1 productive infection in CD4-negative effector memory
T lymphocytes
To characterize the immunophenotypes of HIV-1 productively
infected cells in NOG-hCD34 mice, splenic mononuclear cells fromanalysis in thymi of mock-, HIV-1JR-CSF-, and HIV-1NL4-3-infected mice. The numbers in
and the percentages of DP cells in CD45+ thymocytes (C) in mock-infected (n=4), HIV-
CD8 SP, and DP cells in thymi of mock-infected (n=4), HIV-1JR-CSF-infected (n=6), and
error bars in B and C show standard deviations. Asterisks indicate statistical signiﬁcance
ce when compared to HIV-1JR-CSF-infected mice.
Fig. 3. Histological analysis on R5 HIV-1-infected mice. Representative immunohistological analysis of CD4 (green) and HIV-1 p24 (red) in the slices of bone marrow, spleen, and
lymph nodes of HIV-1JR-CSF-infected NOG-hCD34 mice. The lowmagniﬁcation images of the bone marrow slices were taken at ×80, and the high magniﬁcation images were taken at
×160. The low magniﬁcation images of the spleen and lymph nodes slices were taken at ×40, and the high magniﬁcation images were taken at ×80. The areas enclosed with the
white squares were enlarged. The arrows point at representative CD4+ cells and the arrowheads point at representative CD4+p24+ cells. Scale bars, 50 μm.
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p24 and the expression of lymphocyte surface markers. The anti-p24
antibody that we used did not react with any of the cells isolated
from the mock-infected mice (Fig. 5A), as reported previously
(Okuma et al., 2008). A signiﬁcant fraction of splenic leukocytes
expressed HIV-1 p24 and thus was productively infected with HIV-1
(Fig. 5A). The productively infected cells expressed surface CD3 but
lacked surface CD4 (Figs. 5B and C). On average, over 90% of the p24+
cells were CD3+, yet only about 5% of these cells expressed surface
CD4 (Fig. 5C). Also, p24-expressing cells were positive for CD45RO
but not for CD45RA, suggesting that they were memory T
lymphocytes (73.7±24.3% for CD45RO+CD45RA− in p24+ cells;
Figs. 5D and E). Central memory T lymphocyte (TCM) can be deﬁned
as a memory T lymphocyte that expresses CCR7, and effector memory
T lymphocyte (TEM) can be deﬁned as a memory T lymphocyte that
lacks CCR7 (Sallusto, Geginat, and Lanzavecchia, 2004). In p24-
positive cells, 88.0±3.75% was negative for CCR7 (Figs. 5D and F),
suggesting that TEM dominantly and productively infect with HIV-1.
Productive HIV-1 infection in activated and dividing lymphocytes
To investigate the activation status of the productively infected
cells, splenic mononuclear cells were stainedwith anti-p24, anti-Ki67,
and anti-CD69 antibodies. Ki67 antigen is exclusively expressed in
proliferating cells, and CD69 is expressed on the surface of the
activated cells at the early phase (Sereti et al., 2007; Vatakis et al.,
2007). In splenic CD4+ T lymphocytes from mock-infected mice or
p24-negative splenocytes from HIV-1JR-CSF-infected mice, only aminor fraction of the cells expressed either Ki67 or CD69 (Figs. 6A
and B). In contrast, the majority of p24-positive splenocytes from
HIV-1JR-CSF-infected mice expressed Ki67 and/or CD69 (Figs. 6A and
B). Also, the percentage of cells positive for both Ki67 and CD69 were
higher in p24-positive cells than in p24-negative splenocytes from
HIV-1JR-CSF-infected mice and in splenic CD4+ T lymphocytes from
mock-infected mice (Fig. 6B). These results indicate that a signiﬁ-
cantly higher frequency of p24-positive cells is activated and/or
proliferating cells. Notably, although the frequency was signiﬁcantly
low, we could detect Ki67−CD69− resting T lymphocytes in p24-
positive cells (Figs. 6A and B).
To further analyze the cell cycle of HIV-1 productively infected
cells (i.e., p24-positive cells), we carried out Hoechst staining, which
quantiﬁes DNA content of the cells. Ki67 staining in combination
with the Hoechst staining will sort cells into those in G0/G1a, G1b, and
S/G2/M phases of the cell cycle (Wilpshaar et al., 2000). As shown in
Fig. 6C, non-stimulated human peripheral blood leukocytes (PBLs)
predominantly exist in G0/G1a phases (Ki67−Hoechstlow, lower left
in the quadrant), while PHA-activated human PBLs predominantly
exist in cycling G1b phase (Ki67+Hoechstlow, upper left in the
quadrant) and S/G2/M phases (Ki67+Hoechsthigh, upper right in the
quadrant). By using this method, we observed that p24-positive cells
contained a signiﬁcantly higher frequency of cells in the G1b phase. In
addition, the percentage of p24-positive cells in S/G2/M phases was
signiﬁcantly higher than CD4+ splenocytes from mock-infected mice
(Figs. 6D and E). These ﬁndings indicate that the majority of HIV-1-
producing cells in the spleen of R5 HIV-1-infected mice are activated
and in cycling phase. On the other hand, we detected the p24-
Fig. 4. The effect of R5 HIV-1 infection on the splenic CD4+ T lymphocyte population.
(A–C) Staining of splenic nucleated cells from the spleen of mock-infected (n=4) and
HIV-1JR-CSF-infected (n=4)mice were stained with CD4 (A), CD4 and CD45RA (B), and
CCR5, CD4, and CD45RA (C). Representative proﬁles are shown, and the numbers in dot
plots indicate the percentage of cells in CD45+ splenic human leukocytes (A and B) or in
CD4+ cells (C). The graphs show the percentages of cells possessing each phenotype in
whole mononuclear cells. The error bars show standard deviations. Asterisks indicate
statistical signiﬁcance (Pb0.05) when compared to mock-infected mice.
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signiﬁcantly lower than p24-negative splenocytes or CD4+ spleno-
cytes from mock-infected mice (Figs. 6D and E). These data suggest
that a fraction of resting cells productively infects HIV-1. Moreover,
we detected the signiﬁcantly higher percentage of cells in S/G2/M
phases in splenic p24-negative cells of HIV-1JR-CSF-infected mice
when comparing to that in splenic CD4+ T lymphocytes of mock-
infected mice (Figs. 6D and E).Fig. 5. Phenotype of productively infected p24+ cells in the spleen of R5 HIV-1-infected mic
of mock-infected (n=4) and HIV-1JR-CSF-infected (n=6) mice. The numbers indicate the pe
of HIV-1JR-CSF-infected mice for p24, CD3, and CD4. Representative proﬁles are shown in B
percentages of each population in p24+ cells are shown in C. (D–F) Staining of spleni
Representative proﬁles are shown in D, and the numbers in each quadrant indicate the p
percentages of memory (CD45RA−CD45RO+) and naïve (CD45RA+CD45RO−) phenotyped
and TCM (CCR7+CD45RA−CD45RO+) in p24+ cells are shown in F. The error bars in C, E,Discussion
To investigate themechanisms of CD4+ T lymphocyte depletion by
HIV-1 infection, we utilize human CD34+ cells-transplanted NOG
mice (Ito et al., 2002) and demonstrate that human CD4+ T lympho-
cytes were differentially affected by X4 and R5 HIV-1 infection (Figs.
1–4). X4 virus induced immediate depletion of both naïve and
memory CD4+ T lymphocytes in periphery, while R5 virus gradually
depleted memory CD4+ T lymphocytes in the PB (Fig. 1) and spleen
(Fig. 4). Our data suggest that distinctive pathogenesis of X4 and R5
viruses in NOG-hCD34 mice was caused by thymopathy (Fig. 2) and
preferential infection of activated and dividing TEM (Figs. 5 and 6),
respectively. This is the ﬁrst report addressing the mechanisms and
dynamics of HIV-1-induced CD4+ T lymphocyte depletion in vivo.
As previously shown in X4 SHIV-infected macaques (Ho et al.,
2005; Nishimura et al., 2004), we observed the drastic loss of both
naïve and memory T lymphocytes by X4 HIV-1-infected NOG-hCD34
mice (Fig. 1). We also found that CD4+ thymocytes in NOG-hCD34
mice abundantly express CXCR4 (Fig. 2A) and that the CD4+
thymocytes including DP and CD4 SP were preferentially reduced in
HIV-1NL4-3-infected mice (Fig. 2). It has been reported that intrathy-
mic infection by X4 HIV-1 can lead to severe T lymphocytopenia
(Berkowitz et al., 1998; Schnittman et al., 1990; Ye, Kirschner, and
Kourtis, 2004). Therefore, our results suggest that the primary me-
chanism for naïve and memory T lymphocyte depletion in X4 virus
infection can be attributed to impaired thymopoiesis caused by
intrathymic infection.
In contrast to X4 HIV-1 infection, the depletion of PB CD4+ T
lymphocytes was more gradual and less intense in R5 HIV-1 infection
and was conﬁned to CD45RA− memory CD4+ T lymphocytes (Fig.
1D). The selective depletion of memory CD4+ T lymphocytes by R5
infection was also found in the spleen (Fig. 4). On the other hand,
thymopathy was not detected in HIV-1JR-CSF-infected mice (Fig. 2).
These ﬁndings suggest that the selective depletion of memory CD4+ T
lymphocytes in PB and spleen of HIV-1JR-CSF-infected mice caused
through a different mechanism from HIV-1NL4-3, and the mechanisms
are further discussed below.
To investigate the mechanisms of memory CD4+ T lymphocyte
depletion in R5 HIV-1 infection in-depth, a series of ﬂow cytometric
analyses was carried out. The majority of p24+ productively infected
cells in the spleen were CD3+ T lymphocytes (Figs. 5B and C).
However, these infected cells were negative for surface CD4 (Figs. 5Be. (A) Representative proﬁles of ﬂow cytometric p24 staining in splenic nucleated cells
rcentage of cells in splenic nucleated cells. (B and C) Staining of splenic nucleated cells
, and the numbers in each quadrant indicate the percentage of cells in p24+ cells. The
c nucleated cells of HIV-1JR-CSF-infected mice for p24, CD45RA, CD45RO, and CCR7.
ercentage of cells in p24+ cells (left) or in p24+CD45RA−CD45RO+ cells (right). The
cells in p24+ cells are shown in E. The percentages of TEM (CCR7−CD45RA−CD45RO+)
and F show standard deviations. Asterisks indicate statistical signiﬁcance (Pb0.05).
Fig. 6. Cell cycle analyses on productively infected p24+ cells in the spleen of R5 HIV-1-
infected mice. (A and B) Staining of splenic nucleated cells of mock-infected (n=3)
and HIV-1JR-CSF-infected (n=4) mice for Ki67, CD69, and either CD4 or p24. Repre-
sentative proﬁles are shown in A, and each number indicates the percentage of cells
in each quadrant. The graph in B shows the average percentages of cells possessing
each population. (C) A representative proﬁle of cell cycle analysis on non-stimulated
human PBL (left panel) and PHA-activated human PBL (right panel) by using anti-Ki67
antibody and Hoechst. Each number indicates the percentage of cells in each quadrant.
Ki67−Hoechstlow (lower left in quadrant) indicates G0/G1a phase, while Ki67+Hoechstlow
(upper left in quadrant) and Ki67+Hoechsthigh (upper right in quadrant) indicate G1b and
S/G2/M phases, respectively. (D and E) Staining of splenic nucleated cells of mock-
infectedmice (n=4) for CD4, Ki67, and Hoechst, andHIV-1JR-CSF-infectedmice (n=4) for
p24, Ki67, and Hoechst. Representative proﬁles are shown in D, and each number
indicates the percentage of cells in each quadrant. The graph in E shows the average
percentages of cells in each population. The error bars in B and E show standard
deviations. Asterisks indicate statistical signiﬁcance (Pb0.05) when compared to the
value of p24-negative cells in HIV-1JR-CSF-infected mice, and daggers indicate statistical
signiﬁcance when compared to the value of CD4-positive cells in mock-infected mice.
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p24+ cells expressed CD4 molecules (Fig. 3). These results suggest
that surface CD4 molecules are severely down-regulated following
infection. In fact, it has been well documented that HIV-1 gene
products such as Nef (Fackler, Alcover, and Schwartz, 2007; Roeth andCollins, 2006), Env (Crise, Buonocore, and Rose, 1990), and Vpu (Bour
and Strebel, 2003; Geleziunas, Bour, and Wainberg, 1994) have the
potential to down-regulate CD4 molecules from the surface of
infected cells (Lindwasser, Chaudhuri, and Bonifacino, 2007). Similar
down-regulation of surface CD4 has also been reported in lymph
nodes and PB of HIV-1-infected patients (Cheney et al., 2006; Kaiser et
al., 2007; Marodon et al., 1999). Therefore, this down-regulation of
surface CD4 molecules in HIV-1JR-CSF-infected mice is physiologically
relevant and can play a role in the reduction of CD4+ T lymphocytes.
In HIV-1JR-CSF-infected mice, more than 80% of the productively
infected cells were activated and in cycling phase (Fig. 6). It has been
well known that activated cells massively produce HIV-1 virions (Ho
et al., 1995). Therefore, this result suggests that the persistent viremia
in R5 infection (Fig. 1A) is primarily due to the productive infection in
the activated and proliferating cells. On the other hand, a fraction of
infected cells were quiescent T lymphocytes negative for both
activation and proliferation markers (Fig. 6). It is thought that HIV-1
cannot manifest productive infection in quiescent cells (Stevenson
et al., 1990; Zack et al., 1990). However, studies on ex vivo infected
human tonsil histocultures (Eckstein et al., 2001; Kinter et al., 2003),
small intestines and cervix of SIV-infected rhesus macaques (Li et al.,
2005; Zhang et al., 1999; Zhang et al., 2004), and HIV-1-infected
patients (Zhang et al., 1999) have established that quiescent T lym-
phocytes residing in the lymphoid tissues are capable of supporting
productive SIV or HIV-1 infection. Our results provide further support
that productive infection of HIV-1 can take place in non-dividing cells,
presumably resting T lymphocytes, in NOG-hCD34 mice. Productive
infection not only in proliferative cells but also in quiescent cells may
be an important factor in CD4+ T lymphocyte depletion and persistent
virus infection.
The preferential infection of CD45RO+CD45RA− memory T
lymphocytes with R5 HIV-1 is also the evidence supportive for the
selective depletion of memory CD4+ T lymphocytes (Figs. 5D and E).
Nevertheless, only 16.3±9.7% of splenic CD4+ T lymphocytes
expressed CCR5 in NOG-hCD34 mice, and the severe depletion of
memory T lymphocytes in R5 HIV-1 infection cannot be explained by
cell death caused by infection solely. In this regard, it has been
reported that memory CD4+ T lymphocyte reduction in SIV-infected
macaques can be initiated by speciﬁc disruption of TEM due to its
preferential infection in the acute phase (Centlivre et al., 2007;
Mattapallil et al., 2005; Okoye et al., 2007). In response to the TEM
reduction, TCM proliferates and supplies de novo TEM (Sallusto,
Geginat, and Lanzavecchia, 2004). However, Brenchley et al. (2004)
and Okoye et al. (2007) have reported that R5 virus infection induces
chronic immune activation in macaques, which leads to the
attenuation of regenerative capacity of TCM (Brenchley et al., 2004;
Okoye et al., 2007). In addition to the depletion of TEM by direct
infection, the attenuation of regenerative potential of TCM causes not
only the loss of TCM but also the shortage of TEM and eventually leads
to the reduction of whole memory T lymphocytes (Brenchley et al.,
2004; Okoye et al., 2007). This hypothesis of the dynamics of CD4+ T
lymphocyte depletion has been helpful for explaining the memory
CD4+ T lymphocyte in effector sites of SIV-infected macaques. Our
observations in HIV-1JR-CSF-infected mice, the severe depletion of
memory T lymphocytes despite the limited availability of CCR5-
expressing CD4+ T lymphocytes and the preferential infection in TEM,
can be explained by the aforementioned hypothesis proposed in the
previous literature (Brenchley et al., 2004; Okoye et al., 2007).
Notably, we found that the frequency of cells in S/G2/M phases
elevated in splenic p24-negative cells of HIV-1JR-CSF-infected mice
when comparing to that in splenic CD4+ T lymphocytes of mock-
infected mice (Figs. 6D and E). These data may explain that HIV-1
pathophysiology is caused by accelerated cells division, ultimately
leading to the exhaustion of CD4+ T lymphocytes. Taken together, our
ﬁndings suggest that the selective infection of TEM may be an
important event that governs CD4+ T lymphocyte depletion not
70 C. Nie et al. / Virology 394 (2009) 64–72only in the effector sites of macaques during SIV infection but also in
lymphoid organs during HIV-1 infection.
In summary, we showed differential CD4+ T lymphocyte reduction
in R5 and X4 HIV-1 infection. We report for the ﬁrst time the selective
depletion of memory CD4+ T lymphocytes and the preferential
infection of TEM in an experimental model of R5 HIV-1 infection. Our
data suggest that HIV-1 infection in TEM can be an important step
leading to CD4+ T lymphocyte decline. Our ﬁndings conﬁrm the
applicability of NOG-hCD34 mice as a useful model to study the
dynamics of HIV-1 pathogenesis including CD4+ T lymphocytes
depletion in vivo.
Materials and methods
Mice
NOD/SCID/IL-2Rγnull (NOG) mice (Ito et al., 2002) were obtained
from the Central Institute for Experimental Animals (Kanagawa,
Japan). The mice were maintained under speciﬁc pathogen-free con-
ditions and were handled in accordance with the Regulation on
Animal Experimentation at Kyoto University.
Puriﬁcation and transplantation of cord blood-derived CD34 cells
The puriﬁcation of cord blood-derived CD34 cells was conducted
as described previously (Ishikawa et al., 2005; Ito et al., 2002). Fresh
human cord blood was obtained with parent written informed
consent from healthy full-term newborns and CD34 MicroBead Kit
(Miltenyi Biotec Inc, Auburn, CA) was used to isolate hCD34+ cells
according to the manufacturer's instructions. Cells were either stored
at −80 °C or immediately transplanted when newborn mice were
available. CD34+ cells (5–12×104) were intrahepatically injected into
newborn mice of ages between 0 and 2 days after total radiation of
10 cGy per mouse in MBR-1520 x-ray irradiator (Hitachi Medico,
Tokyo, Japan).
Peripheral blood collection and isolation of nucleated cells from organs
PB was routinely taken from NOG-hCD34 mice under ether
anesthesia via retro-orbital venousplexus as described previously
(Ishikawa et al., 2005). The red blood cells in the PB were lysed in
preparation for ﬂow cytometric analysis in 1× BD lysis buffer (BD
Pharmingen, San Diego, CA). When the mice were sacriﬁced, PB was
taken by cardiac puncture. Lymph nodes, thymi, spleen, and bone
marrow were taken from HIV-1-infected and mock-infected mice
upon sacriﬁce for histological or ﬂow cytometric analysis. Lymph
nodes and thymi were gently homogenized using a homogenizer
pestle and spleens were crushed and rubbed on a steal mesh with 1-
mm grids to generate single cell suspensions in RPMI 1640
supplemented with 4% fetal calf serum (FCS). To collect bone marrow,
thigh bones were dissected at both ends and the interior was ﬂushed
with RPMI 1640 supplemented with 4% FCS. The cells were imme-
diately used for ﬂow cytometric analysis or stored in Cell Banker (Juji
Field Inc., Tokyo, Japan) at −80 °C until use. As there are some
variations in the combination of antibodies used to study the human
cell population in each mouse, the number of data collected for each
surface marker may differ. Data used for any longitudinal analysis
were taken from identical mice.
Flow cytometric analysis of human blood cells in transplanted mice
The staining for ﬂow cytometric analysis was done with some
modiﬁcations to the protocol previously described (Sato et al., 2008).
Brieﬂy, for the surface staining, the cells were blocked with FcR
blocker (Miltenyi Biotec Inc) for 5 min at room temperature (RT)
and then incubated with the appropriate antibodies at optimumconcentration in 1× phosphate-buffered saline (PBS) containing
2% FCS for 30 min at 4 °C. Fluorescein isothiocyanate-conjugated
(FITC-conjugated) anti-human CD19 (HD37; Dako, Tokyo, Japan), CD8
(DK25; Dako), CD14 (TUK4; Miltenyi Biotec Inc), CD4 (L3T4; eBio-
science, San Diego, CA), CD3 (UCHT1; BD Pharmingen, San Diego, CA),
CCR5 (3A9; BD Pharmingen), and CD303/BDCA2 (AC144; Miltenyi
Biotec Inc) mouse IgG monoclonal antibodies (mAb); phycoerythrin-
conjugated anti-human CD3 (UCHT1; Dako), CD4 (MT310; Dako),
CD34 (AC136; Miltenyi Biotec Inc), CD11c (B-ly6; BD Pharmingen),
CXCR4 (12G5; BD Pharmingen), CCR7 (FAB197; R&D systems,
Abingdon, UK), and CCR5 (3A9; BD Pharmingen) mouse IgG mAb;
biotinylated anti-human CD45 (H130; eBioscience), CD45RA (HI-100;
BD Pharmingen), CD8 (RPA-T8; BD Pharmingen), CD4 (RPA-T4; BD
Pharmingen), and mouse IgG mAb; peridinin-chlorophyll-conjugated
(PerCP-conjugated) anti-human CD69 (L78; BD Immunocytometry
Systems, San Jose, CA) mouse IgG mAb; PE-Cy5-conjugated anti-
human HLA-DR (G46-6; BD Pharmingen) mouse IgG mAb; allophy-
cocyamin-conjugated anti-human CD45RO (UCHL1; BD Pharmingen)
and CD8 (DK25; Dako) mouse IgG mAb were used. Each antibody was
controlled with appropriate isotype antibodies purchased from Dako
and BD Pharmingen. Streptavidin-PerCP (SA-PerCP) was purchased
from BD Immunocytometry Systems. Following the incubation, the
cells were washed and further incubated with SA-PerCP for 30 min at
4 °C, if needed. For the intracellular staining, the cells were per-
meabilized and ﬁxed by treatment with BD Cytoperm/Cytoﬁx
solution (BD Pharmingen) and were stained with FITC-conjugated
anti-HIV-1 p24 (clone 2C2) (Okuma et al., 2008) and anti-human Ki67
(B56; BD Pharmingen) mouse IgG mAb for 30 min at 4°C in 1× BD
PermWash buffer (BD Pharmingen). For DNA staining to analyze cell
cycle, the cells were incubated with Hoechst33342 (Invitrogen,
Carlsbad, CA) for 30 min at 4 °C as described previously (Wilpshaar
et al., 2000). Data collection was performed on BD FACSCan (BD
Biosciences) for 3-color staining, BD FACSCalibur (BD Biosciences) for
4-color staining, and BD FACSCanto (BD Biosciences) for cell cycle
analyses using Hoechst33342, and the obtained data were analyzed
with CellQuest software (BD Immunocytometry System, San Jose, CA).
HIV-1 infection
NOG mice were injected intraperitoneally with RPMI 1640 (n=8)
or 1×105 50% tissue culture infective doses (TCID50) of HIV-1JR-CSF
(n=7) or HIV-1NL4-3 (n=8) between 12 and 13 weeks of ages. The
viruses used were prepared by transfection as previously described
(Sato et al., 2008). Infectious titers in the form of TCID50 of each virus
stock were determined by endpoint dilution with phytohemaggluti-
nin-activated PBMCs as described (Koyanagi et al., 1997).
Detection of HIV-1 RNA in the plasma of infected mice
The detection of HIV-1 RNA in the plasma of the infected mice
was routinely carried out using Amplicor HIV-1 monitor v1.5
according to the manufacturer's protocol (Roche Diagnostics, Man-
nheim, Germany).
Immunohistological analysis
Organs were ﬁxed in 1× PBS containing 4% paraformalhyde and
embedded in OCT compound (Sakura Finetechnical, Tokyo, Japan)
after immersion in 10%–20% gradient sucrose. The OCT embedded
organs were then sliced and were permeabilized with 0.1% Triton-X
at RT for 10 min, incubated three times with 10 mM glycine for 5 min
and blocked with 5% normal goat serum at RT for 1 hr. The sections
were then incubated with mouse anti-HIV-1 p24 (Kal-1; Dako) IgG
mAb at 4°C overnight, followed by incubation with Alexa Fluor 488-
conjugated goat anti-mouse IgG (Invitrogen) at RT for 2 hr. The
sections were further incubated with biotinylated mouse anti-
71C. Nie et al. / Virology 394 (2009) 64–72human CD4 IgG mAb (RFT-4g; Southern Biotech, Birmingham, AL) at
4°C overnight, followed by incubation with Streptavidin–Alexa Fluor
647 (Invitrogen) and Hoeschst33342 at RT for 2 hr. All the antibody
staining was performed in blocking solution. Images were acquired
with a Leica TCS SP2 AOBS confocal laser microscope (Leica
Microsystems, Heidelberg, Germany).
Statistical analysis
Data were expressed as an average with standard deviation.
Signiﬁcant differences between data groups were determined by
Student's t test or paired t test. A P value less than 0.05 was con-
sidered signiﬁcantly different.
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